Diagnostic Accuracy of PSMA-targeted 18F-Florastamin PET/CT in Intermediate-risk Patients With Suspected Prostate Cancer. Yuei J, Jung W, Won KS, Shin TJ, et al. Clin Nucl Med 2025;50:e352-e359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yuei J, Jung W, Won KS, Shin TJ, et al. Diagnostic Accuracy of PSMA-targeted 18F-Florastamin PET/CT in Intermediate-risk Patients With Suspected Prostate Cancer. Clin Nucl Med 2025;50:e352-e359.
PMID: 40320630